M.T. Allende

771 total citations
25 papers, 589 citations indexed

About

M.T. Allende is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, M.T. Allende has authored 25 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in M.T. Allende's work include Renal Diseases and Glomerulopathies (4 papers), Protease and Inhibitor Mechanisms (3 papers) and HER2/EGFR in Cancer Research (3 papers). M.T. Allende is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Protease and Inhibitor Mechanisms (3 papers) and HER2/EGFR in Cancer Research (3 papers). M.T. Allende collaborates with scholars based in Spain, United States and Belgium. M.T. Allende's co-authors include Francisco J. Vizoso, Luis Sánchez‐Pulido, Carlos López-Otı́n, Álvaro Ruibal, Irene Diez‐Itza, Santiago Ramón y Cajal, Syong Hyun Nam‐Cha, Juan F. Garcı́a, Miguel Á. Piris and Santiago Montes‐Moreno and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and European Journal of Cancer.

In The Last Decade

M.T. Allende

24 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.T. Allende Spain 13 184 165 150 122 99 25 589
Gilad W. Vainer Israel 14 297 1.6× 257 1.6× 213 1.4× 73 0.6× 78 0.8× 28 700
Y Sugisaki Japan 10 269 1.5× 89 0.5× 87 0.6× 96 0.8× 191 1.9× 26 713
Gongmin Zhu China 11 471 2.6× 206 1.2× 133 0.9× 98 0.8× 106 1.1× 16 765
Nel R. Blom Netherlands 11 130 0.7× 52 0.3× 80 0.5× 71 0.6× 96 1.0× 22 600
Xiaoying Zhao China 14 203 1.1× 250 1.5× 79 0.5× 198 1.6× 110 1.1× 36 651
Takayuki Katsuyama Japan 16 263 1.4× 124 0.8× 94 0.6× 55 0.5× 308 3.1× 47 792
Raymond D. Pastore United States 6 545 3.0× 216 1.3× 65 0.4× 97 0.8× 86 0.9× 11 768
Julie Madden United Kingdom 9 214 1.2× 212 1.3× 49 0.3× 36 0.3× 110 1.1× 14 502
T Brown United States 14 267 1.5× 293 1.8× 123 0.8× 103 0.8× 28 0.3× 43 903
Sevasti Kamina Greece 17 183 1.0× 291 1.8× 143 1.0× 151 1.2× 56 0.6× 36 610

Countries citing papers authored by M.T. Allende

Since Specialization
Citations

This map shows the geographic impact of M.T. Allende's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.T. Allende with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.T. Allende more than expected).

Fields of papers citing papers by M.T. Allende

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.T. Allende. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.T. Allende. The network helps show where M.T. Allende may publish in the future.

Co-authorship network of co-authors of M.T. Allende

This figure shows the co-authorship network connecting the top 25 collaborators of M.T. Allende. A scholar is included among the top collaborators of M.T. Allende based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.T. Allende. M.T. Allende is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allende, M.T., et al.. (2025). Assessment and management of portal hypertension in patients with MASLD: advances and caveats. Expert Review of Gastroenterology & Hepatology. 19(8). 903–917.
2.
Allende, M.T., Jorge Zerón-Medina, Javier Hernández‐Losa, et al.. (2017). Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis. Pancreas. 46(7). 913–920. 51 indexed citations
3.
Vaquero, Eva C., M.T. Allende, Míriam Cuatrecasas, et al.. (2014). Autoimmune pancreatitis type-1 associated with intraduct papillary mucinous neoplasm: Report of two cases. Pancreatology. 14(4). 316–318. 14 indexed citations
4.
5.
6.
7.
8.
Martínez-González, Itziar, Oriol Roca, Joan Ramón Masclans, et al.. (2013). Human Mesenchymal Stem Cells Overexpressing the IL-33 Antagonist Soluble IL-1 Receptor–Like–1 Attenuate Endotoxin-Induced Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 49(4). 552–562. 74 indexed citations
9.
Cedrés, S., Pablo Martínez, Alex Martínez‐Martí, et al.. (2012). Exploratory analysis of activation of PTEN–PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM). Lung Cancer. 77(1). 192–198. 55 indexed citations
10.
Tornavaca, Olga, Eduard Sarró, Gloria Pascual, et al.. (2011). KAP Degradation by Calpain Is Associated with CK2 Phosphorylation and Provides a Novel Mechanism for Cyclosporine A-Induced Proximal Tubule Injury. PLoS ONE. 6(9). e25746–e25746. 8 indexed citations
11.
Soucek, Laura, Joseph J. Buggy, Roderik M. Kortlever, et al.. (2011). Modeling Pharmacological Inhibition of Mast Cell Degranulation as a Therapy for Insulinoma. Neoplasia. 13(11). 1093–IN43. 52 indexed citations
12.
Nam‐Cha, Syong Hyun, et al.. (2009). Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers. Modern Pathology. 22(8). 1006–1015. 68 indexed citations
13.
Casar, José M. del, Adam P. Martin, Carmen García, et al.. (2008). Characterization of breast cancer subtypes by quantitative assessment of biological parameters: Relationship with clinicopathological characteristics, biological features and prognosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 141(2). 147–152. 12 indexed citations
14.
Ferreres, Joan Carles, Elena Martínez‐Sáez, Teresa Vendrell, et al.. (2008). Pathological Findings in the Complete Trisomy 9 Syndrome: Three Case Reports and Review of the Literature. Pediatric and Developmental Pathology. 11(1). 23–29. 11 indexed citations
15.
Corte‐Torres, María D., Julio Vázquez, Juan Carlos Rodrı́guez, et al.. (2005). Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA). Journal of Cancer Research and Clinical Oncology. 131(11). 701–714. 4 indexed citations
16.
Allende, M.T., et al.. (2005). Distress in oncology patients: Distress thermometer in a Latin American study. Journal of Clinical Oncology. 23(16_suppl). 8211–8211. 6 indexed citations
17.
Sanz, Lourdes, et al.. (2002). Prognostic Significance of Tissue-Type Plasminogen Activator (tPA) Content in Gastric Cancer and Surrounding Mucosa. The International Journal of Biological Markers. 17(3). 169–176. 5 indexed citations
18.
Collazos, J., J Genollá, M.T. Allende, & Á. Ruibal. (1993). Serum CA 125 levels in patients with non-malignant liver diseases without ascites. Journal of Molecular Medicine. 71(3). 239–239. 1 indexed citations
19.
Diez‐Itza, Irene, Luis Sánchez‐Pulido, M.T. Allende, et al.. (1993). Zn-α2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters. European Journal of Cancer. 29(9). 1256–1260. 91 indexed citations
20.
Sánchez‐Pulido, Luis, Francisco J. Vizoso, M.T. Allende, Álvaro Ruibal, & Carlos López-Otı́n. (1992). Quantification and molecular analysis of cathepsin D in breast cyst fluids. European Journal of Cancer. 28(4-5). 828–832. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilad W. Vainer Breakdown of academic impact, for papers by Y Sugisaki Breakdown of academic impact, for papers by Gongmin Zhu Breakdown of academic impact, for papers by Nel R. Blom Breakdown of academic impact, for papers by Xiaoying Zhao Breakdown of academic impact, for papers by Takayuki Katsuyama Breakdown of academic impact, for papers by Raymond D. Pastore Breakdown of academic impact, for papers by Julie Madden Breakdown of academic impact, for papers by T Brown Breakdown of academic impact, for papers by Sevasti Kamina
Rankless by CCL
2026